West Pharmaceutical Services (WST) Fell To A 5-Month Low On Outlook

West Pharmaceutical Services (WST) reported fourth quarter adjusted EPS of $0.64 Thursday morning, compared to $0.54 in the prior year period. Analysts expected EPS of $0.63. Full year 2018 adjusted EPS is expected to be between $2.80 and $2.90. The consensus estimate is for EPS of $2.90.

from RTT - Before the Bell http://ift.tt/2CpB5gk
via IFTTT